Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents
| dc.contributor.author | Thomas, K.D. | |
| dc.contributor.author | Vasudeva Adhikari, A.V. | |
| dc.contributor.author | Telkar, S. | |
| dc.contributor.author | Chowdhury, I.H. | |
| dc.contributor.author | Mahmood, R. | |
| dc.contributor.author | Pal, N.K. | |
| dc.contributor.author | Guru Row, T.N.G. | |
| dc.contributor.author | Sumesh, E. | |
| dc.date.accessioned | 2026-02-05T09:35:37Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | Three new series of 4-hydroxy-8-trifluoromethyl-quinoline derivatives were synthesized through multi step reactions. All the newly synthesized compounds were characterized by spectral and elemental analyses. The structure of 5j was evidenced by X-ray crystallographic study. The newly synthesized title compounds were evaluated for their antimicrobial activities including antimycobacterial activity. Amongst the tested compounds, 5b, 5e, 5h, 5j, 6c and 7c displayed promising antimicrobial activity. The mode of action of these active compounds was carried out by docking of receptor enoyl-ACP reductase with newly synthesized candidate ligands, 5b, 5e, 5h, 5j and 6c. © 2011 Elsevier Masson SAS. All rights reserved. | |
| dc.identifier.citation | European Journal of Medicinal Chemistry, 2011, 46, 11, pp. 5283-5292 | |
| dc.identifier.issn | 2235234 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ejmech.2011.07.033 | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/27160 | |
| dc.subject | 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl n (4 methoxyphenyl)hydrazinecarboxamide | |
| dc.subject | 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl] n (4 methylphenyl)hydrazinecarbothioamide | |
| dc.subject | 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl] n (4 methylphenyl)hydrazinecarboxamide | |
| dc.subject | 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl] n (pyridin 3 yl)hydrazinecarbothioamide | |
| dc.subject | 2 [[4 hydroxy 8 (trifluoromethyl)uinoline 3 yl]carbonyl] n (4 methoxyphenyl)hydrazinecarbothioamide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (1 methyl 1h benzotriazol 5 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (1 methyl 1h pyrrol 2 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (2 fluoro 4 methoxy benzylidene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (2 methylsulfanyl benzylidene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (3 hydroxy 4 methoxy benzylidene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (3h imidazol 4 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (4 methoxy benzylidene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (5 fluoro 2 hydroxy benzylidene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (5 methoxy 1h indol 3 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (5 methyl 3h imidazol 4 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid (7 methyl 1h indol 3 ylmethylene)hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid [4 (1,1,2,2 tetrafluoro ethoxy) benzylidene]hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid benzo[1,2,5]oxadiazol 5 ylmethylene hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid benzofuran 5 ylmethylene hydrazide | |
| dc.subject | 4 hydroxy 8 trifluoromethyl quinoline 3 carboxylic acid pyridin 4 ylmethylene hydrazide | |
| dc.subject | 4 hydroxy n' [(e) (4 methylphenyl)methylidene] 8 (trifluoromethyl)quinoline 3 carbohydrazide | |
| dc.subject | acetic acid 4 [(4 hydroxy 8 trifluoromethyl quinoline 3 carbonyl)hydrazonomethyl] furan 2 ylmethylester | |
| dc.subject | hydrazide derivative | |
| dc.subject | n (2 fluorophenyl) 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl]hydrazinecarbothioamide | |
| dc.subject | n (3 chlorophenyl) 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl]hydrazinecarbothioamide | |
| dc.subject | n (3 chlorophenyl) 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl]hydrazinecarboxamide | |
| dc.subject | n (3,5 dimethylphenyl) 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl]hydrazinecarboxamide | |
| dc.subject | n (4 ethylphenyl) 2 [[4 hydroxy 8 (trifluoromethyl)quinolin 3 yl]carbonyl]hydrazinecarboxamide | |
| dc.subject | quinoline derivative | |
| dc.subject | tuberculostatic agent | |
| dc.subject | unclassified drug | |
| dc.subject | antimicrobial activity | |
| dc.subject | article | |
| dc.subject | drug design | |
| dc.subject | drug structure | |
| dc.subject | drug synthesis | |
| dc.subject | in vitro study | |
| dc.subject | X ray crystallography | |
| dc.subject | Antitubercular Agents | |
| dc.subject | Bacteria | |
| dc.subject | Drug Design | |
| dc.subject | Hydrazines | |
| dc.subject | Microbial Sensitivity Tests | |
| dc.subject | Models, Molecular | |
| dc.subject | Molecular Conformation | |
| dc.subject | Quinolines | |
| dc.title | Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents |
